Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
First Atlantic Nickel to Attend North American Stainless & Special Alloys Conference 2025, Highlighting Pipestone XL Nickel Alloy Project's Smelter-Free Processing and Chromium Byproduct Potential for
-
Xunlei Limited Schedules 2025 Unaudited Third Quarter Earnings Release on November 13, 2025
-
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
Cartesian Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates
-
Blue Gold Limited Opens Registration for Standard Gold Coin (SGC), Digital Token Backed by Physical Gold
-
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
-
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF
-
Baker Hughes Secures Additional Order for Rio Grande LNG Expansion
-
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
-
Agora, Inc. to Report Third Quarter 2025 Financial Results on November 19, 2025
-
Tecnoglass Reports Third Quarter 2025 Results
-
Pow.Bio, Bühler, and ATV Technologies Announce Major Advancement in Continuous Biomanufacturing with 3,000-Liter Scale Success
-
CareCloud Reports Third Quarter 2025 Results
-
Microvast Schedules Third Quarter Earnings Call
-
Advantage Solutions Reports Third Quarter 2025 Results
-
Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update
-
Amplify ETFs Named “Best Crypto-Linked ETF Issuer 2025” by ETF Express
-
Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week
-
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
-
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
-
TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of PolyPEPI1018 Plus TAS-102 in Refractory MSS mCRC in JCO Oncology Advances
-
Lantheus Announces Leadership Transition Plan
-
Verano Announces Exclusive Partnership with Raw Garden, a Leading California Cannabis Operator, to Launch Raw Garden Branded Products in New Jersey
-
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Inventus Announces Bulk Sample Processing Underway and Provides Drill Program Update
-
C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Accipiter Biosciences Emerges from Stealth with $12.7 Million in Seed Financing to Deliver de novo Protein Therapies for Complex Diseases
-
Gogo Announces Third Quarter 2025 Results
-
LENSAR® Reports Third Quarter 2025 Results and Provides Business Update
-
Matrix Service Company Announces Award for the Balance of Plant Supporting a Large, Dual Service Full Containment Storage Tank for Delaware River Partners
-
Harvard Bioscience Announces Third Quarter 2025 Financial Results
-
Lifetime Brands, Inc. Reports Third Quarter 2025 Financial Results
-
Datadog Announces Third Quarter 2025 Financial Results
-
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
-
Village Farms International Welcomes Brian Ellis as Chief Information and Technology Officer
-
WeightWatchers Announces Third Quarter 2025 Results
-
Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, “NEO-CYT”, in High-Risk, Surgically Resectable Stage
-
Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
-
Electrokare Launches Groundbreaking Real-Time Electrolyte Tracking Platform to Power the Modern Performance Athlete
-
FactSet Declares Dividend
-
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
-
OTC Markets Group Welcomes SUN SILVER LTD. to OTCQX
-
Marex Group plc announces third quarter 2025 results
-
Immunocore reports third quarter financial results and provides a business update
-
ProQR Announces Third Quarter 2025 Operating and Financial Results
-
Aclaris Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Onity Group Announces Third Quarter 2025 Results

